SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories inks global licensing agreement with Bhami’s Research Laboratory

15 Jun 2026 Evaluate

Ipca Laboratories and Bhami’s Research Laboratory (BRL) have entered into a definitive global licensing agreement. Under the agreement, the company has been granted access to BRL's proprietary high-concentration subcutaneous biologics delivery platform for the development and commercialization of multiple monoclonal antibody products targeting oncology and inflammatory diseases. Further, BRL will receive defined milestone fee pertaining to the Technology Transfer and Royalty on net sales upon commercialization of the product.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.

Ipca Laboratories Share Price

1780.90 62.50 (3.64%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: